000 | 01776 a2200529 4500 | ||
---|---|---|---|
005 | 20250517140549.0 | ||
264 | 0 | _c20180424 | |
008 | 201804s 0 0 eng d | ||
022 | _a1756-185X | ||
024 | 7 |
_a10.1111/1756-185X.13000 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aHiwa, Ryosuke | |
245 | 0 | 0 |
_aOnly rheumatoid factor-positive subset of anti-citrullinated peptide/protein antibody-negative rheumatoid arthritis may seroconvert to anti-citrullinated peptide/protein antibody-positive. _h[electronic resource] |
260 |
_bInternational journal of rheumatic diseases _cJun 2017 |
||
300 |
_a731-736 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aAged |
650 | 0 | 4 |
_aAnti-Citrullinated Protein Antibodies _xblood |
650 | 0 | 4 |
_aArthritis, Rheumatoid _xblood |
650 | 0 | 4 |
_aBiomarkers _xblood |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 |
_aPeptides, Cyclic _ximmunology |
650 | 0 | 4 | _aRetrospective Studies |
650 | 0 | 4 |
_aRheumatoid Factor _xblood |
650 | 0 | 4 | _aSeroconversion |
650 | 0 | 4 | _aSerologic Tests |
650 | 0 | 4 | _aTime Factors |
700 | 1 | _aOhmura, Koichiro | |
700 | 1 | _aNakabo, Shuichiro | |
700 | 1 | _aTerao, Chikashi | |
700 | 1 | _aMurakami, Kosaku | |
700 | 1 | _aNakashima, Ran | |
700 | 1 | _aImura, Yoshitaka | |
700 | 1 | _aYukawa, Naoichiro | |
700 | 1 | _aYoshifuji, Hajime | |
700 | 1 | _aHashimoto, Motomu | |
700 | 1 | _aFuru, Moritoshi | |
700 | 1 | _aIto, Hiromu | |
700 | 1 | _aFujii, Takao | |
700 | 1 | _aMimori, Tsuneyo | |
773 | 0 |
_tInternational journal of rheumatic diseases _gvol. 20 _gno. 6 _gp. 731-736 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1111/1756-185X.13000 _zAvailable from publisher's website |
999 |
_c26880970 _d26880970 |